国家痴呆症工作人员研究:国家老龄化研究所的观点
1National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
Journal of the American Geriatrics Society
|August 28, 2025
概括
全国痴呆症劳动力研究 (NDWS) 是第一个评估痴呆症护理劳动力的大规模调查. 它提供了改善阿尔茨海默病和相关痴呆症患者护理质量和结果的关键数据.
科学领域:
- 老年学
- 医疗服务研究
- 公共卫生
背景情况:
- 随着阿尔茨海默病和相关痴呆症 (AD/ADRD) 的蔓延,需要一个强大而稳定的痴呆症护理工作人员.
- 了解这些工作人员的人口结构,挑战和经验对于确保高质量的痴呆症护理至关重要.
- 现有的知识差距凸显了对痴呆症护理工作人员的全面国家数据的需求.
研究的目的:
- 进行第一个大规模的全国性痴呆症护理工作人员调查.
- 收集有关老年痴呆症护理专业人员和直接护理人员所面临的人口统计,经验和挑战的数据.
- 建立一个数据基础设施,分析影响痴呆症护理质量和结果的劳动力因素.
主要方法:
- 国家痴呆症劳动力研究 (NDWS) 采用了大规模的国家调查设计.
- 数据收集包括医生,高级实践提供者,护士,直接护理工作者和其他卫生专业人员.
- 这项研究涉及四个关键的护理环境:社区医疗机构,养老院,辅助住房和家庭护理.
- 使用与医疗保险索赔和其他健康数据库的创新数据链接.
主要成果:
- 第一个NDWS数据集于2025年7月发布,可免费使用.
- 通过一个安全的网络门户,可以访问链接的NDWS-Medicare数据集.
- 这项研究为回答有关痴呆症护理工作人员的新问题提供了基础.
结论:
- 这项研究的结果将为制定美国痴呆症护理工作人员未来的策略提供信息.
- 这项研究旨在为日益增长的痴呆症患者提供高质量的护理.
- 纵向结果和年度更新将为研究人员,从业人员和决策者提供持续的见解.
相关概念视频
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Pharmacodynamics in Geriatric Patients: Effects of Age
367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367
Aging
1.1K
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
1.1K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35


